Heidi C. Ko

Internal Medicine

7979 Wurzbach Rd
San Antonio, TX 78229

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Machine Learning Algorithm for the Detection of Tumor Microsatellite Instability Based on Multiomics Biomarkers.

Machine Learning Algorithm for the Detection of Tumor Microsatellite Instability Based on Multiomics Biomarkers.

Journal: JCO clinical cancer informatics

Published: June 25, 2026

Correction: RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer.

Correction: RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer.

Journal: Scientific reports

Published: October 23, 2025

Empowering patients for biomarker-informed care: digital education to bridge HER2-low knowledge gaps in metastatic breast cancer.

Empowering patients for biomarker-informed care: digital education to bridge HER2-low knowledge gaps in metastatic breast cancer.

Journal: Frontiers in digital health

Published: September 10, 2025

CD40 transcriptomic expression patterns across malignancies: implications for clinical trials of CD40 agonists.

CD40 transcriptomic expression patterns across malignancies: implications for clinical trials of CD40 agonists.

Journal: Cancer immunology, immunotherapy : CII

Published: June 17, 2025

Utilization of a Multi-modal Comprehensive Genomic and Immune Profiling Testing Strategy Results in a High Rate of Test Success and Detection of Clinically Relevant Biomarkers While Optimizing Tissue Usage.

Utilization of a Multi-modal Comprehensive Genomic and Immune Profiling Testing Strategy Results in a High Rate of Test Success and Detection of Clinically Relevant Biomarkers While Optimizing Tissue Usage.

Journal: Molecular diagnosis & therapy

Published: May 26, 2025

From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates.

From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates.

Journal: Frontiers in oncology

Published: January 23, 2025

Inducible T-Cell Co-Stimulator (ICOS) and ICOS Ligand: Dealing With a Two-Faced Cancer Immunoregulatory System.

Inducible T-Cell Co-Stimulator (ICOS) and ICOS Ligand: Dealing With a Two-Faced Cancer Immunoregulatory System.

Journal: Cancer medicine

Published: December 11, 2024

RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer.

RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer.

Journal: Scientific reports

Published: November 25, 2024

Analysis of real world FRα testing in ovarian, fallopian tube, and primary peritoneal cancers.

Analysis of real world FRα testing in ovarian, fallopian tube, and primary peritoneal cancers.

Journal: Gynecologic oncology

Published: August 30, 2024

Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy.

Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy.

Journal: Frontiers in oncology

Published: July 31, 2024

Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer-a case series of divergent results from a large reference laboratory.

Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer-a case series of divergent results from a large reference laboratory.

Journal: Frontiers in oncology

Published: June 07, 2024

Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer.

Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer.

Journal: Breast cancer (Dove Medical Press)

Published: May 01, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026